Non-alcoholic Fatty Liver Disease : : New Insight and Glance Into Disease Pathogenesis / / edited by Ju-Seop Kang.

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London : : IntechOpen,, 2023.
©2023
Year of Publication:2023
Language:English
Physical Description:1 online resource (ix, 156 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993581460804498
ctrlnum (CKB)5680000000300265
(NjHacI)995680000000300265
(EXLCZ)995680000000300265
collection bib_alma
record_format marc
spelling Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang.
Non-alcoholic Fatty Liver Disease
London : IntechOpen, 2023.
©2023
1 online resource (ix, 156 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.
Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis.
Fatty liver.
1-83968-090-3
1-83968-091-1
Kang, Ju-Seop, editor.
language English
format eBook
author2 Kang, Ju-Seop,
author_facet Kang, Ju-Seop,
author2_variant j s k jsk
author2_role TeilnehmendeR
title Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis /
spellingShingle Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis /
Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis.
title_sub New Insight and Glance Into Disease Pathogenesis /
title_full Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang.
title_fullStr Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang.
title_full_unstemmed Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis / edited by Ju-Seop Kang.
title_auth Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis /
title_alt Non-alcoholic Fatty Liver Disease
title_new Non-alcoholic Fatty Liver Disease :
title_sort non-alcoholic fatty liver disease : new insight and glance into disease pathogenesis /
publisher IntechOpen,
publishDate 2023
physical 1 online resource (ix, 156 pages) : illustrations
contents Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis.
isbn 1-83968-090-3
1-83968-091-1
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC848
callnumber-sort RC 3848 F3 N663 42023
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.362
dewey-sort 3616.362
dewey-raw 616.362
dewey-search 616.362
work_keys_str_mv AT kangjuseop nonalcoholicfattyliverdiseasenewinsightandglanceintodiseasepathogenesis
AT kangjuseop nonalcoholicfattyliverdisease
status_str n
ids_txt_mv (CKB)5680000000300265
(NjHacI)995680000000300265
(EXLCZ)995680000000300265
carrierType_str_mv cr
is_hierarchy_title Non-alcoholic Fatty Liver Disease : New Insight and Glance Into Disease Pathogenesis /
author2_original_writing_str_mv noLinkedField
_version_ 1764995748507680768
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02964nam a2200301 i 4500</leader><controlfield tag="001">993581460804498</controlfield><controlfield tag="005">20230328022920.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230328s2023 enka o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000300265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995680000000300265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000300265</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC848.F3</subfield><subfield code="b">.N663 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.362</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Non-alcoholic Fatty Liver Disease :</subfield><subfield code="b">New Insight and Glance Into Disease Pathogenesis /</subfield><subfield code="c">edited by Ju-Seop Kang.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Non-alcoholic Fatty Liver Disease </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (ix, 156 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Preface -- Section 1 Basic Concept and Molecular Aspect in the Development of NAFLD/NASH -- Chapter 1 Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier by Ibrahim Kalle Kwaifa, Abdullahi S. Mainasara, Muhammad Lawal Jidda, Amrina Mohammad Amin, Garba Abdullahi, Faruku Ladan and Maryam Danyaro -- Chapter 2 Hepatic Lipid Homeostasis in NAFLD by Shuo Zhang, Bing Ji, Changqing Yang and Li Yang -- Chapter 3 Transcriptional Regulation by ERR and Its Role in NAFLD Pathogenesis by Brittney Hua, Ielyzaveta Slarve, Aditi A. Datta, Chenxi Xu, Chien-yu Chen and Bangyan L. Stiles -- Section 2 Therapeutic Aspect Including Iron Metabolism and Heparinase in NAFLD -- Chapter 4 Role of the Enzyme Heparanase in the Development of Fatty Liver by Shadi Hamoud -- Chapter 5 Regulation of Iron Metabolism in NAFLD/NASH by Yuki Hamada and Eiichi Hirano -- Chapter 6 Therapeutic Approach to NAFLD-NASH by Georgios Sfikas and Ioannis Valsamidis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Fatty liver.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83968-090-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83968-091-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Ju-Seop,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:28:01 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5343026330004498&amp;Force_direct=true</subfield><subfield code="Z">5343026330004498</subfield><subfield code="8">5343026330004498</subfield></datafield></record></collection>